US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Matthias Liechti

Recent news which mentions Matthias Liechti

MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
Tickers MNMD
Tags Matthias Liechti ADHD Small Cap
From Benzinga
Antidepressants Can Be Used During Psilocybin Treatment, A New MindMed & Liechti Lab Study Finds
Tickers MNMD
Tags Penny Stocks Education Small Cap
From Benzinga